Cargando…
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
Ketamine, a drug introduced in the 1960s as an anesthetic agent and still used for that purpose, has garnered marked interest over the past two decades as an emerging treatment for major depressive disorder. With increasing evidence of its efficacy in treatment-resistant depression and its potential...
Autores principales: | Matveychuk, Dmitriy, Thomas, Rejish K., Swainson, Jennifer, Khullar, Atul, MacKay, Mary-Anne, Baker, Glen B., Dursun, Serdar M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225830/ https://www.ncbi.nlm.nih.gov/pubmed/32440333 http://dx.doi.org/10.1177/2045125320916657 |
Ejemplares similares
-
Human induced pluripotent stem cells technology in treatment resistant depression: novel strategies and opportunities to unravel ketamine’s fast-acting antidepressant mechanisms
por: Marcatili, Matteo, et al.
Publicado: (2020) -
Apnea during slow sub-anaesthetic infusion of intravenous ketamine for treatment-resistant depression
por: Gómez-Revuelta, Marcos, et al.
Publicado: (2020) -
Association between plasma levels of BDNF and the antisuicidal effects of repeated ketamine infusions in depression with suicidal ideation
por: Zheng, Wei, et al.
Publicado: (2020) -
What combinations of agomelatine with other antidepressants could be successful during the treatment of major depressive disorder or anxiety disorders in clinical practice?
por: Potměšil, Petr
Publicado: (2019) -
Gut feeling: randomized controlled trials of probiotics for the treatment of clinical depression: Systematic review and meta-analysis
por: Nikolova, Viktoriya, et al.
Publicado: (2019)